OptionsHouse

Options Trading News

October 28, 2013  Mon 7:36 AM CT

BMY: SEE CHART GET CHAIN FIND STRATEGIES
Chinese Firms Miss Expectations

The Beijing-based web portal reported an unexpected third-quarter loss of $65 million, citing higher costs and a special dividend. Even worse was disappointing numbers from Sohu's online-game subsidiary Changyou.com, which missed earnings expectations. SOHU is down more than 9 percent to $74, while CYOU plunging about 16 percent to $30 in the pre-market.


Bristol-Myers Higher on Upgrade

The drug developer was upgraded by Morgan Stanley to "overweight" from "equal weight" with a price target of $60, raised from $45. Bristol-Myers Squibb pulled back after reporting quarterly results last week but is bouncing this morning. BMY is up nearly 3 percent to $50.19 on tradeMONSTER's extended-hours platform.
Share this article with your friends


Related Stories

BMY

Bulls keep piling into Bristol-Myers

June 19, 2015

The pharmaceutical company fell sharply in late May because of disappointing data for its lung-cancer drug, but shares have remained above their 100-day moving average.

BMY

Bristol-Myers call buying spikes

June 4, 2015

The stock climbed to its highest price since January 2001 on May 20 but fell sharply last Friday with disappointing data on the company's lung-cancer drug.

OptionsHouse

Premium Services

Archived Webinar

Education & Strategy

Real vs. Synthetic

We now know that there are two ways of creating a call position, a put position, and a stock position. We can simply use the actual real security or we can recreate it synthetically. We can create these positions in both long and short forms and this ability sets up an interesting scenario--an arbitrage!

View more education articles »